To study the effects of simvastatin on lipid profile in obese patients with changing lifestyle

ABSTRACT

Simvastatin is a competitive inhibitor of HMG-CoA [3-hydroxy 3-Methyl glutaryl Coenzyme A] reductase. Present study proposed that the lipid lowering effect of simvastatin may be enhanced, if it was taken with fat free diet and morning walk. Cross Sectional Study. This study was conducted at Fatima Jinnah Medical College, Lahore for a period of six months from December 2009 to May 2010. 20 male and 20 female obese patients were selected. The obese patients were re-examined three times i.e. before giving the simvastatin, then after 6 and 12 weeks. The patients were advised to take fat free diet and a morning walk. Serum Cholesterol, serum Triglycerides and serum Lipoprotiens [HDL, LDL] were determined. This study shows that with use of simvastatin, serum cholesterol, serum triglycerides, and serum LDL-Cholesterol was reduced significantly and serum HDL-Cholesterol increased significantly in both sexes. It was also observed that the fat free diet and some exercise causes weight reduction. It is therefore concluded that simvastatin shows significant lipid lowering effects augment process of body weight reduction, if patients used calorie restricted diet with some morning walk